KemPharm Announces Matthew R. Plooster Named Chairman Of The Board Of Directors And Richard W. Pascoe Appointed Chief Executive Officer
KemPharm Announces Matthew R. Plooster Named Chairman Of The Board Of Directors And Richard W. Pascoe Appointed Chief Executive Officer
KemPharm 宣佈馬修·普洛斯特被任命為董事會主席和理查德 ·W· 帕斯科被任命為首席執行官
KemPharm Announces Matthew R. Plooster Named Chairman Of The Board Of Directors And Richard W. Pascoe Appointed Chief Executive Officer
KemPharm 宣佈馬修·普洛斯特被任命為董事會主席和理查德 ·W· 帕斯科被任命為首席執行官
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。